Search

everythinglearnresearchcommunity

for

Search:↓

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

Growing hair follicles have high mitochondrial activity and ROS in specific regions, aiding hair formation.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Men with testicular cancer were less likely to experience baldness and severe acne.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.